Back to search

Molecule Structure

Scientific Name


Description of the Drug

Sotagliflozin is an orally administered dual SGLT1/2 inhibitor used alongside insulin to improve glycemic control in patients with type 1 diabetes mellitus.

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)

Not Available

Company Owner(s)

Not Available

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sodium/glucose cotransporter 1 SINGLE PROTEIN INHIBITOR CHEMBL4979
Sodium/glucose cotransporter 2 SINGLE PROTEIN INHIBITOR CHEMBL3884

Unichem Links

DrugBank DB12713
PubChem: Thomson Pharma 49853536
PubChem 24831714
BindingDB 50235017
EPA CompTox Dashboard DTXSID20144314
DrugCentral 5339
ChemicalBook CB52516025
Guide to Pharmacology 8312
ZINC ZINC000095641922